ZEN Graphene Solutions Changes Name to Zentek

ZEN Graphene Solutions Ltd.  (TSX.V: ZEN)

A Canadian, intellectual property development company focused on next-gen healthcare solutions, is pleased to announce that it has filed articles of amendment to change its name to Zentek Ltd, which became effective recently.

The ticker remains as ZEN.V

 

.

Zen Graphene TSX.v : ZEN
Stage Exploration
Metals Graphite
Market cap C$566 m   @ 6.37c
Location Ontario, Canada

 

.

Zen graphene coated facemask

Zen graphene coated facemask

.

.

ZEN Graphene Solutions Announces Name Change to Zentek Ltd.

Guelph, ON

ZEN Graphene Solutions Ltd.(“ZEN” or the “Company”) (TSX.V: ZEN and OTC:ZENYF), a Canadian, intellectual property development company focused on next-gen healthcare solutions, is pleased to announce that it has filed articles of amendment to change its name to “Zentek Ltd.” (the “Name Change”).

The Name Change was approved by shareholders of the Company at its annual and special meeting held on September 27, 2021.  The Common Shares are expected to commence trading on the TSX Venture Change under the new name “Zentek Ltd.” on or about November 1, 2021.

The Company’s symbol will remain “ZEN”.  A new CUSIP number has been obtained to replace the previous CUSIP number.

No action will be required by existing shareholders with respect to the Name Change. Certificates representing common shares of the Company will not be affected by the Name Change and will not need to be exchanged. The Company encourages any shareholder with any questions or concerns to contact the Company or to discuss any of the foregoing with their broker or agent.

.

About ZEN Graphene Solutions Ltd.

ZEN is an intellectual property development company developing and commercializing next-gen healthcare solutions in the areas of prevention, detection, and treatment.

ZEN is currently focused on commercializingZENGuardTM, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.

The Company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology.

.

=======

.

City Investors Circle is based in the financial district in the City of London

We present interesting and exciting junior mining companies listed on the ASX and TSX stock exchanges to a group of city professionals, and private investors, all of whom are active investors with a mandate to invest in junior mining companies.

Our audience is selected and invited individually to ensure interest and relevance for the presenting company.

Meetings are non deal, small group, highly focused and engaged, with a lively Q and A to follow the main presentation.

We create awareness, and maintain interest in presenting companies by disseminating their future news to our entire investor group via email, social media, and our Monthly Review newsletter.

If you wish to present to our select group of active mining investors, please email andrew@city-investors-circle.com

.

=======

,

This website is not sponsored, we are truly independent, and will always remain so.

Companies featured here have either presented to the Circle in London, or have been selected because they are considered to have interesting projects, in good jurisdictions, run by an experienced management team.

All information used in the preparation of this communication has been compiled from publicly available sources that we believe to be accurate and reliable, however, we cannot, and do not, guarantee the accuracy or completeness of this.

These articles are for awareness and informational purposes only, and are not recommendations in any form.  Always consult an investment professional.